Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sagent Pharmaceuticals Inc (NASDAQ:SGNT)

15.02
Delayed Data
As of Jun 24
 -0.30 / -1.96%
Today’s Change
10.55
Today|||52-Week Range
26.47
-5.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues183.6M244.8M289.0M318.3M
 
 
 
 
 
Cost of Goods Sold146.5M116.2M193.1M216.9M
 
 
 
 
 
Depreciation And Amortization6.0M7.1M9.5M13.7M
 
 
 
 
 
 
Operating ExpensesGross Income31.1M121.5M86.4M87.7M
 
 
 
 
 
General Expenses47.2M56.0M70.0M79.6M
 
 
 
 
 
Research And Development17.1M19.8M26.8M29.1M
 
 
 
 
 
Total Operating Expenses199.7M179.2M272.7M310.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.1M65.5M16.3M8.1M
 
 
 
 
 
Extraordinary Credit0.007.9M0.00555.0K
 
 
 
Extraordinary Charge-1.1M-44.5M-1.3M-55.8M
 
 
 
 
 
Pre-Tax Equity Earnings1.3M2.4M4.0M2.6M
 
 
 
 
 
Interest Expense On Debt1.2M930.0K2.2M770.0K
 
 
 
 
 
Other Expenses0.000.00-678.0K-2.8M
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.8M30.5M16.2M-48.1M
 
 
 
 
 
Income Taxes0.00-895.0K-23.7M-26.2M
 
 
 
 
Net Income-16.8M29.6M39.9M-21.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.0M29.2M31.9M32.4M
 
 
 
 
 
Shares To Calculate EPS Diluted28.0M29.9M32.7M32.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.60$0.99$1.22-$0.67
 
 
 
 
 
EPS Diluted-$0.60$0.99$1.22-$0.67